⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7063166 | 0.63 | — | — | |
| SCHEMBL51760 | 0.63 | — | — | |
| SCHEMBL1880009 | 0.58 | — | — | |
| SCHEMBL8508392 | 0.54 | — | — | |
| SCHEMBL2105710 | 0.54 | — | — | |
| SCHEMBL2575806 | 0.53 | — | — | |
| SCHEMBL6911599 | 0.53 | — | — | |
| SCHEMBL322277 | 0.50 | — | — | |
| SCHEMBL173026 | 0.50 | — | — | |
| SCHEMBL776455 | 0.50 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112424203-B | Bruton's tyrosine kinase inhibitors | 正大天晴药业集团股份有限公司 | 2022-07-26 | — | — | CN | disclosed |
| CN-111918870-B | Deuterated oligonucleotides and prodrugs | 正大天晴药业集团股份有限公司 | 2022-07-08 | — | — | CN | disclosed |
| US-6627456-B1 | Incorporating into the oligonucleotide analogs that are the components of a library to which in vitro selection methods functionalized standard and non-standard nucleotides, and incorporating functionalized cofactors into the experiment | BENNER, STEVEN | 2003-09-30 | — | — | US | disclosed |
| US-5965364-A | Method for selecting functional deoxyribonucleotide derivatives | BENNER, STEVEN | 1999-10-12 | — | — | US | disclosed |